Call for accelerated rare cancers pathway
Australia should establish a Rare Cancer Therapies Access Accelerator (RaCTAA) as part of a series of reforms to improve access and outcomes for patients, says a new report from Rare Cancers Australia (RCA).
To see the whole article, log in or create an account.